FOXP4-AS1

gene
On this page

Summary

FOXP4-AS1 (FOXP4 antisense RNA 1, HGNC:50332) is a long non-coding RNA gene on chromosome 6p21.1.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:50332
Approved symbolFOXP4-AS1
NameFOXP4 antisense RNA 1
Location6p21.1
Locus typeRNA, long non-coding
StatusApproved
Ensembl geneENSG00000234753
Ensembl biotypelncRNA
Entrez101060264
RNAcentralURS00007E36F3 — lncRNA, 588 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 46 — 46 lncRNA

ENST00000414386, ENST00000432751, ENST00000439386, ENST00000440194, ENST00000454812, ENST00000691406, ENST00000701272, ENST00000727791, ENST00000727792, ENST00000727793, ENST00000727794, ENST00000727795, ENST00000727796, ENST00000727797, ENST00000727798, ENST00000727799, ENST00000727800, ENST00000727801, ENST00000727802, ENST00000727803, ENST00000727804, ENST00000727805, ENST00000727806, ENST00000727807, ENST00000727808, ENST00000727809, ENST00000727810, ENST00000727811, ENST00000727812, ENST00000727813, ENST00000727814, ENST00000727815, ENST00000727816, ENST00000727817, ENST00000727818, ENST00000727819, ENST00000727820, ENST00000727821, ENST00000727822, ENST00000727823, ENST00000727824, ENST00000727825, ENST00000727826, ENST00000727827, ENST00000727828, ENST00000727829

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000414386 — 2 exons

ExonStartEnd
ENSE000040537084152386241524225
ENSE000040537254154608941546344

Expression profiles

Bgee: expression breadth ubiquitous, 153 present calls, max score 74.26.

FANTOM5 (CAGE): breadth broad, TPM avg 0.7944 / max 25.7371, expressed in 361 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
735480.6352308
735470.159374

Top tissues by expression

242 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of transverse colonUBERON:000499174.26gold quality
body of pancreasUBERON:000115074.01gold quality
sural nerveUBERON:001548872.62gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099172.45gold quality
colonic epitheliumUBERON:000039772.04gold quality
calcaneal tendonUBERON:000370171.93gold quality
body of stomachUBERON:000116170.69gold quality
pancreasUBERON:000126470.25gold quality
stomachUBERON:000094570.08gold quality
ventricular zoneUBERON:000305370.01gold quality
rectumUBERON:000105268.83gold quality
bone marrow cellCL:000209267.91silver quality
ganglionic eminenceUBERON:000402367.21gold quality
fundus of stomachUBERON:000116065.88gold quality
islet of LangerhansUBERON:000000665.60gold quality
left lobe of thyroid glandUBERON:000112065.39gold quality
thyroid glandUBERON:000204665.18gold quality
vermiform appendixUBERON:000115463.98gold quality
right lobe of thyroid glandUBERON:000111963.66gold quality
hindlimb stylopod muscleUBERON:000425263.49gold quality
omental fat padUBERON:001041462.73gold quality
peritoneumUBERON:000235862.66gold quality
transverse colonUBERON:000115762.59gold quality
adipose tissue of abdominal regionUBERON:000780862.43gold quality
gall bladderUBERON:000211061.92gold quality
monocyteCL:000057661.29gold quality
adipose tissueUBERON:000101361.00gold quality
tendonUBERON:000004360.40gold quality
prostate glandUBERON:000236760.30gold quality
cortex of kidneyUBERON:000122559.77gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.10

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 12)

  • The lncRNA FOXP4-AS1 expression is up-regulated in CRC tissues and that FOXP4-AS1 overexpression is a poor prognostic factor in colorectal cancer patients. (PMID:27790757)
  • FOXP4-AS1 is overexpressed in osteosarcoma (OS), and is the independent risk factor in OS prognosis. Upregulated FOXP4-AS1 promotes the proliferation, migration and cell cycle, but inhibits apoptosis of OS cells. Furthermore, FOXP4-AS1 participates in the development and progression of OS by downregulating LATS1 via binding to LSD1 and EZH2. (PMID:29859193)
  • paired box 5 (PAX5) transcriptionally activated FOXP4-AS1 and FOXP4 in prostate cancer. (PMID:31209207)
  • Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma. (PMID:31991068)
  • Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma. (PMID:32767327)
  • lncRNA FOXP4AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR4235p/NACC1 pathway. (PMID:33416160)
  • Identification of a Prognostic Colorectal Cancer Model Including LncRNA FOXP4-AS1 and LncRNA BBOX1-AS1 Based on Bioinformatics Analysis. (PMID:33481661)
  • Long Noncoding RNA FOXP4-AS1 Predicts Unfavourable Prognosis and Regulates Proliferation and Invasion in Hepatocellular Carcinoma. (PMID:33604387)
  • FOXP4-AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer. (PMID:33870423)
  • Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2. (PMID:34545456)
  • LncRNA FOXP4-AS promotes the progression of non-small cell lung cancer by regulating the miR-3184-5p/EIF5A axis. (PMID:34921595)
  • The FOXP4-AS1/miR-3130-3p/SP4 feedback loop is associated with prostate cancer. (PMID:37114256)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.